1. Home
  2. TNET vs ZLAB Comparison

TNET vs ZLAB Comparison

Compare TNET & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNET
  • ZLAB
  • Stock Information
  • Founded
  • TNET 1988
  • ZLAB 2013
  • Country
  • TNET United States
  • ZLAB China
  • Employees
  • TNET N/A
  • ZLAB N/A
  • Industry
  • TNET Business Services
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNET Consumer Discretionary
  • ZLAB Health Care
  • Exchange
  • TNET Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • TNET 3.9B
  • ZLAB 3.6B
  • IPO Year
  • TNET 2014
  • ZLAB 2017
  • Fundamental
  • Price
  • TNET $74.64
  • ZLAB $34.55
  • Analyst Decision
  • TNET Hold
  • ZLAB Buy
  • Analyst Count
  • TNET 3
  • ZLAB 4
  • Target Price
  • TNET $90.00
  • ZLAB $47.37
  • AVG Volume (30 Days)
  • TNET 242.8K
  • ZLAB 1.0M
  • Earning Date
  • TNET 07-25-2025
  • ZLAB 08-05-2025
  • Dividend Yield
  • TNET 1.46%
  • ZLAB N/A
  • EPS Growth
  • TNET N/A
  • ZLAB N/A
  • EPS
  • TNET 3.32
  • ZLAB N/A
  • Revenue
  • TNET $4,999,000,000.00
  • ZLAB $418,326,000.00
  • Revenue This Year
  • TNET $1.76
  • ZLAB $44.07
  • Revenue Next Year
  • TNET $4.25
  • ZLAB $49.13
  • P/E Ratio
  • TNET $22.60
  • ZLAB N/A
  • Revenue Growth
  • TNET 1.19
  • ZLAB 43.72
  • 52 Week Low
  • TNET $65.43
  • ZLAB $16.01
  • 52 Week High
  • TNET $116.26
  • ZLAB $44.34
  • Technical
  • Relative Strength Index (RSI)
  • TNET 32.50
  • ZLAB 49.05
  • Support Level
  • TNET $75.66
  • ZLAB $36.36
  • Resistance Level
  • TNET $83.79
  • ZLAB $44.34
  • Average True Range (ATR)
  • TNET 1.88
  • ZLAB 1.45
  • MACD
  • TNET -0.93
  • ZLAB -0.16
  • Stochastic Oscillator
  • TNET 18.16
  • ZLAB 39.20

About TNET TriNet Group Inc.

TriNet offers outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: